Alnylam Pharmaceuticals

Area Sales Manager, Central Italy

Alnylam Pharmaceuticals  •  Rome, IT / Bologna, IT (Remote)  •  3 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Overview

The Area Sales Manager, Central Italy leads and develops a team of Key Account Managers to deliver sustainable commercial results and improve outcomes for patients. Reporting to the National Sales Director, Italy, this role translates brand and country strategy into effective field execution, strengthens account planning and customer engagement, and provides market insights to inform commercial decisions.

The successful candidate will build a high-performing, inclusive team and ensure that all activities are conducted in accordance with applicable laws, industry standards, and Alnylam policies.

Key Responsibilities

Leadership and Team Development

  • Lead, coach, and develop a team of Key Account Managers, fostering an inclusive, high-performing culture.
  • Set clear expectations, provide ongoing feedback, and support employee growth through effective development and succession planning.
  • Build field capabilities through coaching, product and disease education, and best-practice sharing.

Commercial Strategy and Execution

  • Translate country and brand strategy into territory and account plans that support patient identification and the achievement of commercial objectives.
  • Drive execution excellence through rigorous account planning, opportunity assessment, and resource prioritization.
  • Monitor team performance against agreed objectives and key performance indicators, adjusting plans as necessary to maximize results.
  • Support accurate forecasting and provide actionable market intelligence on customer needs, competitive activity, and healthcare trends.
  • Drive healthcare professional education initiatives and market development activities in alignment with business objectives.

Cross-Functional Collaboration

  • Partner closely with Medical, Marketing, Market Access, Business Operations, Training, and Country Leadership to ensure aligned execution.
  • Support the planning and execution of congresses, educational initiatives, sponsorships, and approved commercial activities.
  • Collaborate with internal stakeholders to establish, monitor, and communicate commercial performance metrics.

Compliance and Operational Excellence

  • Ensure all commercial activities are conducted in compliance with applicable Italian laws, industry codes, company policies, and approved promotional practices.
  • Promote effective adoption and use of customer relationship management systems and digital tools to support customer engagement, reporting quality, and forecast accuracy.
  • Ensure timely and accurate documentation, reporting, and communication of field activities.
  • Ensure pharmacovigilance information and product complaints are reported in accordance with company procedures.

Customer Engagement

  • Build and maintain effective relationships with key healthcare stakeholders and decision-makers.
  • Accompany team members in the field, as appropriate, to coach customer engagement and strengthen account planning.
  • Participate directly in strategic customer interactions when required to support business priorities and patient access initiatives.

Qualifications

  • Bachelor's degree or equivalent relevant experience.
  • 5+ years of pharmaceutical, biotechnology, or specialty healthcare commercial experience.
  • Previous people leadership experience with a track record of coaching and developing field teams.
  • Strong knowledge of the Italian healthcare environment.
  • Experience in account planning, forecasting, and performance management.
  • Fluency in Italian and professional proficiency in English.
  • Willingness to travel extensively within Italy.

Preferred qualifications

  • Experience in rare diseases, specialty care, or hospital-based products.
  • Product launch experience.
  • Experience with Veeva or similar CRM platforms.

#LI-LR1 #LI-REMOTE

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

Before applying, please review Alnylam's ⁠Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.

Alnylam Pharmaceuticals

About Alnylam Pharmaceuticals

SILENCE DISEASE. AMPLIFY LIFE.™

Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.

Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.

We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).

We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.

See our social media community guidelines: https://bit.ly/2FcRhJy.

Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Fraudulent Recruitment Activity

Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Industry
Biotech & Life Sciences
Company Size
1,001-5,000 employees
Headquarters
Cambridge, Massachusetts
Year Founded
2002
Social Media